Home

<html><style type=“text/css”> .breadcrumbs {display: none;} .gsc-completion-container { font-family: helvetica, sans-serif !important; font-size: 18px !important; border: 1px solid #666666; margin-left: 0; margin-right: 0; /* The top, left, and width are set in JavaScript. */ -moz-box-shadow: 5px 5px 5px #999; -webkit-box-shadow: 5px 5px 5px #999; box-shadow: 5px 5px 5px #999; background-color: #fafafa; /* Needed for IEs */ }

.gsc-completion-container > tbody { position: relative; /* This protects the inner element from being blurred */ background-color: #DDD; }

.gsc-completion-container > tbody > tr > td { padding: 5px; } td#csc-completion-selected { background: #FEFAF4 !important; }

</style></html>

Home

<WRAP homepage>

<WRAP h2 welcome>Welcome to the MPKB</WRAP>

The <html>Marshall Protocol</html> is a therapy for chronic inflammatory diseases created by Trevor Marshall, PhD. It is based on an explanation for how an infectious cascade of pathogens slow the immune response, allowing subsequent infections to proliferate, thereby causing the symptoms and markers of disease.

<WRAP h2>Search</WRAP><phpinc=homesearch.html> <WRAP tabber><WRAP tabbertab><html><h3>For Patients</h3></html>

</WRAP> <WRAP tabbertab><html><h3>For Physicians</h3></html>

</WRAP></WRAP>

<html><div class=“highlightedh2”>News and highlights </div></html><phpinc=twit.html>

<html><div class=“highlightedh2” style=“margin-top: 18px !important;”>Publications and presentations</div></html>

Immunostimulation in the era of the human metagenome - paper in Molecular and clinical immunology that reviews a case series of <html>Marshall Protocol</html> patients and discusses how immunostimulatory approaches may require rethinking medicine
Autoimmune disease and the human metagenome - book chapter in Springer's Metagenomics of the human body that discusses how the process of <html>successive infection may be responsible for autoimmune disease</html>
Olmesartan overcomes antibiotic resistance, inducing recovery from advanced autoimmune disease – presentation by Trevor Marshall, PhD at International Congress on <html>Autoimmunity</html>
Olmesartan medoxomil and treatment of autoimmune disease – presentation by Greg Blaney, MD

Complete list

<WRAP h4>About the MPKB Project</WRAP>

The MPKB currently contains about 400 pages and draws from the best possible evidence to support its mission. As of May 2011, about 85% of those articles are complete with the remainder scheduled to be completed.

<WRAP h4>About Autoimmunity Research FoundationNon-profit foundation dedicated to exploring a pathogenesis and therapy for chronic disease.</WRAP>

Autoimmunity Research Foundation is a California-based 501©3 (tax deductible) non-profit formed to educate the public about the nature of, and study a treatment for, chronic inflammatory disease.

</WRAP>

home/devel/6.txt · Last modified: 07.04.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.